The Food and Drug Administration (FDA) has issued permission for the first rapid test, which within 15 minutes determines which infection has entered the body – viral or bacterial. The test, called the BV Test, was developed by the Israeli company MeMed with funds from a special grant of $ 30 million from the EU and the US Department of Defense.
It is reported that the test does not determine the cause of the infection, but thanks to the specific analysis of the immune response to viral and bacterial infection, it quickly gives a result. “This is a completely new word in diagnostics,” the Financial Times quotes Louis Bont, professor of pediatrics and infectious diseases specialist at the Utrecht University Medical Center, who took part in clinical trials of the test. Is it caused by a bacterial infection and we can give him an antibiotic, or is it a virus, so the antibiotic cannot be given. “
The MeMed Rapid Test is being tested at the Utrecht Center for three months. Researchers from Harvard Medical School, New York Maimonides Center and Hillel Yaffe Medical Center (Hadera, Israel) also participated in the study and testing of the new test.
Read also:
